4.7 Article

Characterizing the face in facioscapulohumeral muscular dystrophy

期刊

JOURNAL OF NEUROLOGY
卷 268, 期 4, 页码 1342-1350

出版社

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-020-10281-z

关键词

Facioscapulohumeral muscular dystrophy; Facial weakness; Outcome measures

向作者/读者索取更多资源

The study aimed to evaluate facial weakness in FSHD patients and found that patients had significantly higher facial weakness severity compared to controls, with asymmetry between the left and right sides of the face. About 10% of patients had mild facial weakness, and more severe facial weakness correlated with disease severity and gene repeat length, but not disease duration.
Objective To evaluate facial weakness in patients with FSHD to better define clinical signs, and pilot a facial weakness severity score. Methods 87 FSHD patients and 55 controls were video recorded while performing seven facial tasks. The videos were assessed by three independent examiners to compile an overview of signs of facial weakness. Next, videos were semi-quantitatively assessed using a newly developed 4-point facial weakness score (FWS). This score was evaluated and correlated to other FSHD disease characteristics. Results Patients had lower scores on the total FWS than controls (mean score 43 +/- 28, range 4-118, vs 14 +/- 9, range 0-35, p < 0.001) and on all seven individual facial tasks (all p < 0.001). 54% of patients had FWS scores outside the range of controls. Patients had more asymmetry between the left and right side of the face than controls. About 10% of the patients had very mild facial weakness. These were mostly males (89%) with longer D4Z4 repeat sizes of 7-9 units. More severe facial weakness correlated to more severe overall disease severity and shorter D4Z4 repeat size, but not to disease duration. Interobserver agreement for the FWS between three raters was low with a Fleiss Kappa of 0.437. Conclusion This study provides an overview of the clinical spectrum of facial weakness and its relation to other disease characteristics. The 4-point scale we introduced to grade the severity of facial weakness enables correlation of facial weakness to disease characteristics, but is not suited as clinical outcome measure for longitudinal studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据